France's National Assembly has approved a landmark assisted dying bill by 295 votes to 232, reviving legislation that the Senate rejected in January. The vote, which took place on [date], marks a pivotal moment in a years-long debate over end-of-life rights in the Fifth Republic.
"This vote is the culmination of several years of work and of a thorough public debate, conducted with seriousness, respect and dignity," Yaël Braun-Pivet, president of the National Assembly, wrote on X after the result. The bill now returns to the Senate, where it faces an uncertain future; if the two chambers cannot agree, the Assembly can have the final word.
What the Bill Would Change
The proposed law creates a right to aided dying for adults with grave, incurable illnesses in an advanced or terminal phase. Patients must be over 18 and either French citizens or residents. A team of medical professionals must confirm that the patient suffers from constant, intolerable, and untreatable pain linked to their condition, and that they are seeking lethal medication of their own free will.
One significant change from earlier drafts is that psychological suffering alone no longer qualifies for assisted dying. Only patients who are physically unable to administer the substance themselves may have a doctor or nurse do it for them.
The bill also includes a conscience clause allowing healthcare professionals to opt out of participating, provided they refer the patient to another practitioner. Philippe Vigier, the bill's rapporteur, described the final text as having "reached a point of balance," establishing new rights for patients while safeguarding the freedom of professionals and protecting patients, staff, and relatives alike.
Controversy and Criticism
The legislation has sparked fierce debate across France. Critics are divided: some argue that amendments have watered down the original proposal, while others contend it remains too permissive. The bill's journey has been long—President Emmanuel Macron first promised end-of-life legislation in 2022, and the text was officially proposed in 2024. It passed the National Assembly in May 2025, only to be rejected by the Senate on 28 January by 181 votes to 122.
A joint committee of seven senators and seven deputies subsequently failed to reach a compromise, sending the bill back to the lower house. With the Assembly's renewed approval, the ball is now in the Senate's court. If the two chambers still cannot agree, the National Assembly can override the upper house.
The debate comes amid broader discussions about healthcare and social policy in France. The country has recently grappled with excess deaths during heatwaves and nuclear output cuts due to river ecosystem strains, highlighting the intersection of health, environment, and governance.
As the bill moves forward, it remains a deeply personal issue for many French citizens. The outcome will not only shape end-of-life care in France but also influence debates across Europe, where countries like Belgium, the Netherlands, and Switzerland have already legalized some form of assisted dying. For now, all eyes are on the Senate.
